Mayo Clinic Radiotherapy Patient Outcomes Registry and Biobanking Study

Overview

  • Study type

    Observational
  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 15-000136
    • Scottsdale/Phoenix, Arizona: 15-000136
    NCT ID: NCT02457962
    Sponsor Protocol Number: 15-000136

About this study

To collect and analyze specimens that will correlate with clinical outcomes such as acute and late toxicities, quality of life, local control, and survival of patients treated with radiation therapy.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  1. Treated at Mayo Clinic Rochester in Radiation Oncology
  2. Radiation therapy for curative intent

Exclusion Criteria:

  1. None

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Nadia Laack, M.D.

Open for enrollment

Contact information:

Adam Amundson

(507)293-4850

Amundson.Adam1@mayo.edu

Scottsdale/Phoenix, Ariz.

Mayo Clinic principal investigator

Nadia Laack, M.D.

Open for enrollment

Contact information:

Manuel Vargas R.N.

(480)342-4146

Vargas.Manuel@mayo.edu

.
CLS-20147875

Mayo Clinic Footer